Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
David Kotlyar(National Institutes of Health), Gary R. Lichtenstein(University of Pennsylvania), Ann Tierney(University of Pennsylvania), Colleen Brensinger(University of Pennsylvania), Wojciech Błoński(Binghamton University), Laurent Beaugerie(Assistance Publique – Hôpitaux de Paris), James D. Lewis(University of Pennsylvania), Laurent Peyrin‐Biroulet(Délégation Centre-Est), María Chaparro(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Edward V. Loftus(Mayo Clinic), Meenakshi Bewtra(University of Pennsylvania), Florian Beigel(Ludwig-Maximilians-Universität München), Livia Biancone(University of Rome Tor Vergata), Manuel Van Domselaar(Hospital Universitario Ramón y Cajal), Sandipani Sandilya(Montefiore Medical Center), Javier P. Gisbert(Hospital Universitario de La Princesa)
Cited by 405
Related Papers
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Management of <i>Helicobacter pylori</i> infection—the Maastricht IV/ Florence Consensus Report
|Gut|2012|2.3k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k